Non-Coding RNAs as Theranostics in Human Cancers

In Redis et al. the funding information as shown in the Acknowledgments was incomplete. The corrected section is shown below G.A.C. is supported as a Fellow at The University of Texas MD AndersonResearch Trust, as a University of Texas System Regents Research Scholar and by the CLL Global Research Foundation. Work in Dr. Calin's laboratory is supported in part by the NIH/NCI (CA135444), a Department of Defense Breast Cancer Idea Award, Developmental Research Awards in Breast Cancer, Ovarian Cancer, Brain Cancer, Multiple Myeloma and Leukemia SPOREs, a 2009 Seena Magowitz–Pancreatic Cancer Action Network AACR Pilot Grant, and the Laura and John Arnold Foundation and RGK Foundation. Dr. Berindan-Neagoe was financed by a POSCCE grant (709/2010) entitled Clinical and Economical Impact of Proteome and Transcriptome Molecular Profiling in Neoadjuvant Therapy of Triple Negative Breast Cancer (BREASTIMPACT). Redis, RS, Berindan-Neagoe, I, Pop, VI, Calin, GA. 2012. Non-coding RNAs as theranostics in human cancers. J Cell Biochem 113: 1451– 1459. doi: 10.1002/jcb.24038.